Virginia Kimball Dalton

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment
    Virginia Kimball Dalton
    Department of Medicine, Children s Hospital, Boston, MA 02115, USA
    J Clin Oncol 21:2953-60. 2003
  2. ncbi request reprint Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity
    Deborah P Waber
    Department of Psychiatry, Children s Hospital and Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 22:2701-7. 2004
  3. ncbi request reprint Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience
    John M Goldberg
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    J Clin Oncol 21:3616-22. 2003

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment
    Virginia Kimball Dalton
    Department of Medicine, Children s Hospital, Boston, MA 02115, USA
    J Clin Oncol 21:2953-60. 2003
    ....
  2. ncbi request reprint Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity
    Deborah P Waber
    Department of Psychiatry, Children s Hospital and Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 22:2701-7. 2004
    ....
  3. ncbi request reprint Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience
    John M Goldberg
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    J Clin Oncol 21:3616-22. 2003
    ..T-cell acute lymphoblastic leukemia (T-ALL) accounts for 10% to 15% of newly diagnosed cases of childhood acute lymphoblastic leukemia (ALL). Historically, T-ALL patients have had a worse prognosis than other ALL patients...